Adverse drug reactions affecting blood cells

Handbook of Experimental Pharmacology

Volumn 196, Issue , 2010, Pages 57-76

  Aster, Richard H ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Drug sensitivity; Drug induced cytrpennia

Indexed keywords

ABCIXIMAB; ANTIBODY; CARBOPLATIN; CEFTIZOXIME; CEFTRIAXONE; CHLORPROPAMIDE; CISPLATIN; CLOZAPINE; EFALIZUMAB; ETANERCEPT; ETODOLAC; HEPARIN; IBUPROFEN; INFLIXIMAB; LEVODOPA; METHYLDOPA; OXALIPLATIN; PENICILLAMINE; PIPERACILLIN; PROBENECID; PROCAINAMIDE; PROPYLTHIOURACIL; QUINIDINE; QUININE; RITUXIMAB; SULFAMETHOXAZOLE; TIROFIBAN; TOLMETIN; UNINDEXED DRUG; XENOBIOTIC AGENT;

AGRANULOCYTOSIS; APLASTIC ANEMIA; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; BLOOD TOXICITY; CELLULAR IMMUNITY; EFFECTOR CELL; ERYTHROCYTE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; NEUTROPENIA; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTOPENIA; ANIMAL; BLOOD CELL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG THERAPY; HEMATOLOGIC DISEASE; IMMUNOLOGY; POLLUTANT;

ANEMIA, APLASTIC; ANIMALS; BLOOD CELLS; BLOOD PLATELETS; DRUG THERAPY; ENVIRONMENTAL POLLUTANTS; ERYTHROCYTES; HEMATOLOGIC DISEASES; HUMANS; NEUTROPHILS;

EID: 77949331493     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-00663-0_3     Document Type: Review

References (62)

1. Adachi JD, Bensen WG, Kassam Y et al (1987) Gold induced thrombocytopenia: 12 cases and a review of the literature. Semin Arthritis Rheum 16:287-293
2. Andersohn F, Konzen C, Garbe E (2007) Non-chemotherapy drug-induced agranulocytosis: a systematic review of case reports. Ann Intern Med 146:657-665
3. Andrès E, Maloisel F (2008) Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol 15:15-21
4. Andrès E, Maloisel F, Kurtz JE, Kaltenbach G, Alt M, Weber JC et al (2002) Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. Eur J Intern Med 13:324-328
5. Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F (2006) Idiosyncratic druginduced agranulocytosis: update of an old disorder. Eur J Intern Med 17:529-535
6. Arndt PA, Garratty G (2005) The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol 42:137-144 (Pubitemid 41019442)
7. Artoni A, Li J, Mitchell B (2004) et al (2004) Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation. Proc Natl Acad Sci U S A 101:13114-13120
8. Aster RH (2000) Can drugs cause autoimmune thrombocytopenic purpura? Semin Hematol 37:229-238
9. Aster RH, Bougie DW (2007) Drug-induced immune thrombocytopenia. N Engl J Med 357:580-587
10. Bhatt V, Saleem A (2004) Review: drug-induced neutropenia- pathophysiology, clinical features, and management. Ann Clin Lab Sci 34:131-137
11. Bougie D, Aster R (2001) Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen. Blood 97:3846-3850
12. Bougie D, Johnson ST, Weitekamp LA, Aster RH (1997) Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia. Blood 90:407-413
13. Bougie DW, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, Lind RN, Pereira J, Aster RH (2002) Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 100:2071-2076
14. Bougie DW, Wilker PR, Aster RH (2006) Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies. Blood 108:922-927
15. Bougie DW, Benito AI, Sanchez-Abarca LI, Torres R, Birenbaum J, Aster RH (2007) Acute thrombocytopenia caused by sensitivity to the glucuronide conjugate of acetaminophen. Blood 109:3608-3609
16. Christie DJ, Aster RH (1982) Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia. J Clin Invest 70:989-998
17. Christie DJ, Mullen PC, Aster RH (1985) Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 75:310-314
18. Cunha PD, Lord RS, Johnson ST, Wilker PR, Aster RH, Bougie DW (2000) Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion 40:663-668
19. Curtis BR, Swyers J, Divgi A, McFarland JG, Aster RH (2002) Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets. Blood 99:2054-2059
20. Curtis BR, Divgi A, Garritty M, Aster RH (2004) Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. J Thromb Haemost 2:985-992
21. Curtis BR, Kaliszewski J, Marques MB, Saif MW, Nabelle L, Blank J, McFarland JG, Aster RH (2006) Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol 81:193-198
22. Davoren A, Aster RH (2006) Heparin-induced thrombocytopenia and thrombosis. Am J Hematol 81:36-44
23. Dlott JS, Danielson CF, Blue-Hnidy DE, McCarthy LJ (2004) Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review. Ther Apher Dial 8:102-111
24. FibbeWE, Claas FH,Van Der Star-Dijkstra W, Schaafsma MR,Meyboom RH, Falkenburg JH(1986) Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol 64:363-373
25. Garratty G (1993) Immune cytopenia associated with antibiotics. Transfus Med Rev 7:255-267
26. Garratty G, Arndt PA (2007) An update on drug-induced immune hemolytic anemia. Immunohematology 23:105-119
27. Garratty G, Arndt P, Prince HE, Shulman IA (1993) The effect of methyldopa and procainamide on suppressor cell activity in relation to red cell autoantibody production. Br J Haematol 84:310-315
28. Gottschall JL, Elliot W, Lianos E, McFarland JG, Wolfmeyer K, Aster RH (1991) Quinineinduced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity. Blood 77:306-310
29. Green FA, Jung CY, Rampal A, Lorusso DJ (1980) Alpha-methyldopa and the erythrocyte membrane. Clin Exp Immunol 40:554-560
30. Guest I, Uetrecht J (1991) Drugs that induce neutropenia/agranulocytosis may target specific components of the stromal cell extracellular matrix. Med Hypotheses 53:145-151
31. Ibáñez L, Sabaté M, Ballarín E, Puig R, Vidal X, Laporte JR (2008) Agranulocytosis and Aplastic Anaemia Study Group of Barcelona. Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis. Pharmacoepidemiol Drug Saf 17:224-228
32. Johnson ST, Fueger JT, Gottschall JL (2007) One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia-a new paradigm. Transfusion 47:697-702
33. Juang YC, Tsao TC, Chiang YC, Lin JL, Tsai YH (1992) Acute renal failure and severe thrombocytopenia induced by rifampicin: report of a case. J Formos Med Assoc 91:475-476
34. Kaufman DW et al. (1996) Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol 60(Suppl):55-59
35. Kojouri K, Vesely SK, George JN (2001) Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med 135:1047-1051
36. Maloisel F, Andrès E, Kaltenbach G, Noel E, Martin-Hunyadi C, Dufour P (2004) Prognostic factors of hematological recovery in life-threatening nonchemotherapy drug-induced agranulocytosis. A study of 91 patients from a single center. Presse Med 33:1164-1168
37. Mascelli MA, Lance ET, Damaraju L, Wagner CL, Weisman HF, Jordan RE (1998) Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade. Circulation 97:1680-1688
38. McMinn JR Jr, Cohen S, Moore J, Lilly S, Parkhurst J, Tarantino MD, Terrell DR, George JN (2003) Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol 73:135-140
39. Montané E, Ibáñez L, Vidal X, Ballarín E, Puig R, García N, Laporte JR (2008) Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica 93:518-523
40. Otrock ZK, Mahfouz RA, Oghlakian GO, Salem ZM, Bazarbachi A (2005) Rituximab-induced acute thrombocytopenia: a report of two cases. Haematologica 90(Suppl):ECR23
41. Petz LD (1993) Drug-induced autoimmune hemolytic anemia. Transfus Med Rev 7:242-254
42. Reddy JC, Shuman MA, Aster RH (2004) Quinine/quinidine-induced thrombocytopenia: a great imitator. Arch Intern Med 164:218-220
43. Reid DM, Shulman NR (1988) Drug purpura due to surreptitious quinidine intake. Ann Intern Med 108:206-208
44. Salama A, Mueller-Eckhardt C (1985) The role of metabolite-specific antibodies in nomifensinedependent immune hemolytic anemia. N Engl J Med 313:469-474
45. Salama A, Mueller-Eckhardt C (1987) On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood 69:1006-1010
46. Salama A, Göttsche B, Mueller-Eckhardt C (1991) Autoantibodies and drug- or metabolitedependent antibodies in patients with diclofenac-induced immune haemolysis. Br J Haematol 77:546-549
47. Salamon DJ, Nusbacher J, Stroupe T, Wilson JH, Hanrahan JB (2004) Red cell and platelet-bound IgGpenicillin antibodies in a patient with thrombocytopenia. Semin ThrombHemost 30:273-283
48. Shulman NR (1964) A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in autoimmunity. Ann Int Med 60:506-521
49. Shulman NR, Reid DM (1993) Mechanisms of drug-induced immunologically mediated cytopenias. Transfus Med Rev 7:215-229
50. Smith ME, Reid DM, Jones CE, Jordan JV, Kautz CA, Shulman NR (1987) Binding of quinineand quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent. J Clin Invest 79:912-917
51. Sosler SD, Behzad O, Garratty G, Lee CL, Postaway N, Khomo O (1984) Acute hemolytic anemia associated with a chlorpropamide-induced apparent auto-anti-Jka. Transfusion 24:206-209
52. Stroncek DF, Herr GP, Maguire RB, Eiber G, Clement LT (1994) Characterization of the neutrophil molecules identified by quinine-dependent antibodies from two patients. Transfusion 34:980-985
53. Vidal F, Fontova R, Richart C (2003) Severe neutropenia and thrombocytopenia associated with infliximab. Ann Intern Med 139:W1-W63
54. Visentin GP, Wolfmeyer K, Newman PJ, Aster RH (1990) Detection of drug-dependent, plateletreactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion 30:694-700
55. Von Dem Borne AE, Pegels JG, Van Der Stadt RJ, van der Plas-van Dalen CM, Helmerhorst FM (1986) Thrombocytopenia associated with gold therapy: a drug-induced autoimmune disease? Br J Haematol 63:509-516
56. Warkentin TE (2004) An overview of the heparin-induced thrombocytopenia syndrome. SeminThromb Hemost 30:273-283
57. Warkentin TE (2007) Heparin-induced thrombocytopenia. Hematol Oncol Clin N Am 21:589-607
58. Warkentin TE, Kwon P (2005) Immune thrombocytopenia associated with efalizumab therapy for psoriasis. Ann Intern Med 143:761-763
59. Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK (2000) Induction of metabolismdependent and -independent neutrophil apoptosis by clozapine. Mol Pharmacol 58:207-216
60. Wolf B, Conradty M, Grohmann R, Ruther E, Witzgall H, Londong V (1989) A case of immune complex hemolytic anemia, thrombocytopenia, and acute renal failure associated with doxepin use. J Clin Psychiatry 50:99-100
61. Young NS, Kaufman DW (2008) The epidemiology of acquired aplastic anemia. Haematologica 93:489-492
62. Young NS, Scheinberg P, Calado RT (2008) Aplastic anemia. Curr Opin Hematol 15:162-168